Electrochemical control of cell death by reduction-induced intrinsic apoptosis and oxidation-induced necrosis on CoCrMo alloy in vitro.
Electrochemical voltage shifts in metallic biomedical implants occur in-vivo due to a number of processes including mechanically assisted corrosion. These excursions may compromise the biocompatibility of metallic implants. Voltages can also be controlled to modulate cell function and fate. The in vitro effect of static voltages on the behavior of MC3T3-E1 pre-osteoblasts cultured on CoCrMo alloy (ASTM-1537) was studied to determine the range of cell viability and mode of cell death beyond the viable range. Cell viability and morphology, changes in actin cytoskeleton, adhesion complexes and nucleus, and mode of cell death (necrosis, or intrinsic or extrinsic apoptosis) were characterized at different voltages ranging from -1000 to +500 mV (Ag/AgCl). Moreover, electrochemical currents and metal ion concentrations at each voltage were measured and related to the observed responses. Results show that cathodic and anodic voltages outside the voltage viability range (-400 < V < +500) lead to primarily intrinsic apoptotic and necrotic cell death, respectively. Cell death is associated with cathodic current densities of 0.1 μA cm(-2) and anodic current densities of 10 μA cm(-2). Significant increase in metallic ions (Co, Cr, Ni, Mo) was seen at +500 mV, and -1000 mV (Cr only) compared to open circuit potential. The number and total projected area of adhesion complexes was also lower on the polarized alloy (p < 0.05). These results show that reduction reactions on CoCrMo alloys leads to apoptosis of cells on the surface and may be a relevant mode of cell death for metallic implants in-vivo.
Department of Biomedical and Chemical Engineering, Syracuse University, Syracuse, NY 13244, USA.
Morteza
M
Haeri
Torsten
T
Wӧllert
George M
GM
Langford
Jeremy L
JL
Gilbert
D000497:Alloys / Q000494:pharmacology*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D053148:Caspase 3 / Q000378:metabolism; D053453:Caspase 9 / Q000378:metabolism; D002448:Cell Adhesion / Q000187:drug effects; D002460:Cell Line; D053145:Cell Nucleus Size / Q000187:drug effects; D048430:Cell Shape / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003035:Cobalt / Q000494:pharmacology*; D003470:Culture Media / Q000737:chemistry; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism; D004560:Electricity; D004563:Electrochemistry / Q000379:methods*; D005453:Fluorescence; D007477:Ions; D051379:Mice; D008954:Models, Biological; D009336:Necrosis / Q000473:pathology*; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D010084:Oxidation-Reduction / Q000187:drug effects; D014800:Vitallium / Q000494:pharmacology*
D000497:Alloys; D003470:Culture Media; D007477:Ions; D014800:Vitallium; D003035:Cobalt; D053148:Caspase 3; D053453:Caspase 9